New Agents for Heart Failure: Ivabradine
Ivabradine, an f-channel inhibitor that slows heart rate in patients with heart failure with reduced ejection fraction, significantly reduces the frequency of cardiovascular death or hospitalization for worsening heart failure and improves quality of life
▶︎
Integrating Advances in Heart Failure: Part 1
▶︎
Update on Novel Therapies for Heart Failure (Milton Packer, MD) February, 10, 2017
▶︎
Antineoplastic Agents | Clinical Medicine
▶︎
Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction
▶︎
Right Heart Catheterization and Hemodynamic Assessment
▶︎
How Your Brain Works & Changes | Huberman Lab Essentials
▶︎
Medical breakthroughs and health stories | 60 Minutes Marathon
▶︎
New Agents for Heart Failure: Sacubitril/Valsartan
▶︎
내몸에닥터 #60. 심장 초음파로 무엇을 알 수 있을까요? (내과 전문의 류재춘 & 정진희 PD) (대한내과의사회)
▶︎
#1 Best AT HOME Test to Find Clogged Arteries
▶︎
Heart Failure with Preserved Ejection Fraction: Five Common Myths - Grand Rounds with James Fang, MD
▶︎
Antiarrhythmic Drug Classes
▶︎
Beat Afib: Treatment and Latest Advancements
▶︎
Living With A Pacemaker (common questions answered) - in Plain English!
▶︎
PARADIGM-HF — The Experts’ Discussion
▶︎
Kidney Disease in Aging: Causes, Symptoms, & Treatment
▶︎
Ivabradine
▶︎
Lipoprotein(a) or Lp(a) : What you Need To Know
▶︎
Learning To Live With Heart Failure
▶︎